Articles

Quick Take on OpenAI's New Models: o3, o4-mini — What Can Image Reasoning + Autonomous Tools Bring? | Yunqi Tech π

Quick Take on OpenAI's New Models: o3, o4-mini — What Can Image Reasoning + Autonomous Tools Bring? | Yunqi Tech π

In the early hours of April 17 Beijing time, OpenAI released two new AI reasoning models, o3 and o4-mini. These are likely the last standalone AI reasoning models before GPT-5, with further improvements in both performance and cost efficiency. In this episode of **"Yunqi Tech π"**, we break down the details for you.

Qiming Star | Ark Biosciences Announces Latest Research Results for First RSV-Specific Antiviral Drug Ziresovir Published in The Lancet Child & Adolescent Health | Bilingual

Qiming Star | Ark Biosciences Announces Latest Research Results for First RSV-Specific Antiviral Drug Ziresovir Published in The Lancet Child & Adolescent Health | Bilingual

This study, the world's first Phase 3 clinical trial covering RSV-infected infants under six months of age, successfully fills the evidence gap for targeted treatment approaches in this high-risk population and provides critical evidence for building a comprehensive RSV disease management system.

Yuantian Biotechnology Closes Nearly 100 Million Yuan Pre-A+ Round, Dalton Venture Bets on Enzymatic PET Recycling | Dalton News

Yuantian Biotechnology Closes Nearly 100 Million Yuan Pre-A+ Round, Dalton Venture Bets on Enzymatic PET Recycling | Dalton News

Recently, **Yuantian Biotechnology (Tianjin) Co., Ltd. (hereinafter referred to as "Yuantian Bio") announced the completion of a nearly 100 million yuan Pre-A+ funding round, with Dalton Venture participating in this round** to support the company's kiloton-scale production line construction, product technology advancement, and market expansion.